Carcinoma-associated mucin serum markers CA M26 and CA M29: efficacy in detecting and monitoring patients with cancer of the breast, colon, ovary, endometrium and cervix.

K A Yedema; P Kenemans; T Wobbes; G J van Kamp; H W de Bruijn; C M Thomas; L F Massuger; C P Schijf; G G Bon; J B Vermorken

doi:10.1002/ijc.2910470203

Carcinoma-associated mucin serum markers CA M26 and CA M29: efficacy in detecting and monitoring patients with cancer of the breast, colon, ovary, endometrium and cervix.

Identifier:nobleid.org/w1/20260515/2C88EB0A

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2C88EB0A.svg?ark=w1%2F20260515%2F2C88EB0A)](https://nobleid.org/work/w1/20260515/2C88EB0A)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Carcinoma-associated mucin serum markers CA M26 and CA M29: efficacy in detecting and monitoring patients with cancer of the breast, colon, ovary, endometrium and cervix.

Identifier:nobleid.org/w1/20260515/2C88EB0A

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2C88EB0A.svg?ark=w1%2F20260515%2F2C88EB0A)](https://nobleid.org/work/w1/20260515/2C88EB0A)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work